Accordingly, the Parliament resolved— That the Parliament recognises the scale and urgency of unmet need in both mental health and neurodevelopmental support, particularly in the context of a sharp rise in demand for neurodiversity assessments and treatment for adults and children following the COVID-19 pandemic; notes the additional pressure on services caused by the global shortage of attention deficit hyperactivity disorder (ADHD) medication, which has led to the closure of titration clinics in some areas and significantly impacted waiting times and access to care; recognises the profound distress and disruption this causes for individuals and families who are left without timely diagnosis or support; acknowledges the knock-on effects on the health service, as well as the wider economic consequences of rising levels of economic inactivity linked to unmet neurodevelopmental and mental health needs; notes with concern the widespread removal of shared care arrangements where patients who obtained a private diagnosis could receive ongoing care and medication through the Scottish NHS; calls on the Scottish Government to work urgently with NHS boards and local authorities on their shared care arrangement protocols, but understands that decisions around the best...